These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20552613)

  • 1. Mechanism and clinical significance of the prothrombotic state in patients with essential hypertension.
    Yang P; Liu YF; Yang L; Wei Q; Zeng H
    Clin Cardiol; 2010 Jun; 33(6):E81-6. PubMed ID: 20552613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Naoxinduotai capsule on markers of prothrombotic state in patients with essential hypertension].
    Yang J; Wang G; Wang Y; Yuan S; Zhou D
    Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(24):3382-5. PubMed ID: 21438412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension.
    Preston RA; Coffey JO; Materson BJ; Ledford M; Alonso AB
    Atherosclerosis; 2007 May; 192(1):148-54. PubMed ID: 16764881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension.
    Lip GY; Blann AD; Edmunds E; Beevers DG
    Blood Coagul Fibrinolysis; 2002 Jan; 13(1):35-41. PubMed ID: 11994565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.
    Vyssoulis GP; Marinakis AG; Aznaouridis KA; Karpanou EA; Arapogianni AN; Cokkinos DV; Stefanadis CI
    Am J Hypertens; 2004 Jul; 17(7):582-9. PubMed ID: 15233977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercoagulability markers in patients with peripheral arterial disease: association to ankle-brachial index.
    Mota AP; de Castro Santos ME; Lima e Silva Fd; de Carvalho Schachnik NC; de Oliveira Sousa M; das Graças Carvalho M
    Angiology; 2009; 60(5):529-35. PubMed ID: 19015166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary thrombus composition: links with inflammation, platelet and endothelial markers.
    Sadowski M; Ząbczyk M; Undas A
    Atherosclerosis; 2014 Dec; 237(2):555-61. PubMed ID: 25463088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet adhesion in hypertension: application of a novel assay of platelet adhesion.
    Nadar SK; Caine GJ; Blann AD; Lip GY
    Ann Med; 2005; 37(1):55-60. PubMed ID: 15902847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
    Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
    J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological Response to Trauma-Induced Coagulopathy: A Comprehensive Review.
    Duque P; Mora L; Levy JH; Schöchl H
    Anesth Analg; 2020 Mar; 130(3):654-664. PubMed ID: 31633501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study.
    Catena C; Colussi G; Fedrizzi S; Sechi LA
    J Hypertens; 2013 Oct; 31(10):2077-84. PubMed ID: 24107736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies.
    Martinuzzo ME; Forastiero RR; Kordich L; Carreras LO
    Br J Haematol; 2001 Sep; 114(4):845-51. PubMed ID: 11564073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of renin-angiotensin system in prothrombotic state in essential hypertension.
    Remková A; Remko M
    Physiol Res; 2010; 59(1):13-23. PubMed ID: 19249905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activity and hypercoagulation in type 2 diabetes.
    Pretorius L; Thomson GJA; Adams RCM; Nell TA; Laubscher WA; Pretorius E
    Cardiovasc Diabetol; 2018 Nov; 17(1):141. PubMed ID: 30388964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients.
    Ouviña SM; La Greca RD; Zanaro NL; Palmer L; Sassetti B
    Thromb Res; 2001 Apr; 102(2):107-14. PubMed ID: 11323020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prothrombotic state in hypertension and the effects of antihypertensive treatment.
    Nadar S; Lip GY
    Curr Pharm Des; 2003; 9(21):1715-32. PubMed ID: 12871204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.